1,963
Views
39
CrossRef citations to date
0
Altmetric
Articles

Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines

&
Pages 731-739 | Received 15 Jul 2016, Accepted 11 Nov 2016, Published online: 07 Dec 2016

References

  • Abrams RM, Gerhardt KJ. 2000. The acoustic environment and physiological responses of the fetus. J Perinatol. 20:S31–S36.
  • Adabi M, Naghibzadeh M, Adabi M, et al. 2016. Biocompatibility and nanostructured materials: applications in nanomedicine. Artif Cells Nanomedicine Biotechnol. 1401:1–10.
  • Anand-Srivastava MB, Trachte GJ. 1993. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev. 2:455–497.
  • Baharvand B, Dehaj ME, Rasoulian B, et al. 2009. Delayed anti-arrhythmic effect of nitroglycerin in anesthetized rats: involvement of CGRP, PKC and mK ATP channels. Int J Cardiol. 135:187–192.
  • Barry SP, Davidson SM, Townsend P. a. 2008. Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol. 40:2023–2039.
  • Berger J, Reist M, Mayer JM, et al. 2004. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm. 19–34.
  • Calderone A, Thaik CM, Takahashi N, et al. 1998. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 101:812–818.
  • Choi EH, Lee N, Kim HJ, et al. 2008. Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes. Genes Nutr. 2:337–345.
  • Dabrowska K, Stuss M, Gromadzińska J, et al. 2008. The effects of melatonin on glutathione peroxidase activity in serum and erythrocytes after adriamycin in normal and pinealectomised rats. Endokrynol Pol. 59:200–206.
  • Daraee H, Eatemadi A, Abbasi E, et al. 2014. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomedicine Biotechnol. 1401:1–13. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25229833.
  • Daraee H, Etemadi A, Kouhi M, et al. 2014. Application of liposomes in medicine and drug delivery. Artif Cells Nanomedicine Biotechnol. 44:1–11.
  • De Beer EL, Bottone AE, Voest EE. 2001. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur J Pharmacol. 415:1–11.
  • Dessì-Fulgheri P, Sarzani R, Tamburrini P, et al. 1997. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 15:1695–1699.
  • Duvoix A, Blasius R, Delhalle S, et al. 2005. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223:181–190.
  • Eatemadi A, Daraee H, Karimkhanloo H, et al. 2014. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 9:1–13.
  • Eatemadi A, Daraee H, Zarghami N, et al. 2014. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomedicine Biotechnol. 44:1–11.
  • Ghafarzadeh M, Namdari M, Eatemadi A. 2016. Stem cell therapies for congenital heart disease. Biomed. Pharmacother. 84:1163–1171. [Internet]. Available from: http://www.sciencedirect.com/science/article/pii/S0753332216317942.
  • Ghosh AK, Kay NE, Secreto CR, et al. 2009. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin Cancer Res. 15:1250–1258.
  • Hamza A, Amin A, Daoud S. 2008. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol. 24:63–73.
  • Hirooka Y, Takeshita A, Imaizumi T, et al. 1990. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation. 82:147–153.
  • Izumo S, Lompré AM, Matsuoka R, et al. 1987. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest. 79:970–977.
  • Khosravi AR, Pourmoqhadas M, Ostovan M, et al. 2011. The impact of generic form of clopidogrel on cardiovascular events in patients with coronary artery stent: results of the OPCES study. J Res Med Sci. 16.
  • Khosravi AR, Raoufi A, Pourmoghadas M, et al. 2013. Late clinical events of drug eluting versus bare metal stenting; OPCES’ ancillary study. Pakistan J Med Sci. 29:258–263.
  • Knowles JW, Esposito G, Mao L, et al. 2001. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest. 107:975–984.
  • Lemke K. a, Dawson SD. 2000. Local and regional anesthesia. Vet Clin North Am Small Anim Pract. 30:839–857.
  • Lopez MJ, Wong SK, Kishimoto I, et al. 1995. Salt-resistant hypertension in mice lacking the guanylyl cyclase – a receptor for atrial natriuretic peptide. Nature. 378:65–68.
  • Mahdavi V, Lompre AM, Chambers AP, et al. 1984. Cardiac myosin heavy chain isozymic transitions during development and under pathological conditions are regulated at the level of mRNA availability. Eur Heart J. 5:181–191.
  • Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47:469–474.
  • Mohamad RH, El-Bastawesy AM, Zekry ZK, et al. 2009. The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food. 12:394–402.
  • Mou X, Ali Z, Li S, et al. 2015. Applications of magnetic nanoparticles in targeted drug delivery system. J Nanosci Nanotechnol. 15:54–62.
  • Nakayama T, Soma M, Takahashi Y, et al. 2000. Functional deletion mutation of the 5’-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res. 86:841–845.
  • Namdari M, Eatemadi A. 2016. Nanofibrous bioengineered heart valve – application in paediatric medicine. Biomed Pharmacother. 84:1179–1188. [Internet]. Available from: http://www.sciencedirect.com/science/article/pii/S0753332216318522.
  • Oliver PM, Fox JE, Kim R, et al. 1997. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA.94:14730–14735.
  • Preuss HG, Jarrell ST, Scheckenbach R, et al. 1998. Comparative effects of chromium, vanadium and gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr. 17:116–123.
  • Reiser PJ, Portman M. a, Ning XH, et al. 2001. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol. 280:H1814–H1820.
  • Roy M, Chakraborty S, Siddiqi M, et al. 2002. Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac J Cancer Prev. 3:61–67.
  • Sanphui P, Goud NR, Khandavilli UBR, et al. 2011. New polymorphs of curcumin. Chem. Commun (Camb.). 47:5013
  • Seidi K, Eatemadi A, Mansoori B, et al. 2014. Nanomagnet-based detoxifying machine: an alternative/complementary approach in HIV therapy. J AIDS Clin Res. 25:304.
  • Srivastava G, Mehta JL. 2009. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther. 14:22–27.
  • Swamy AV, Gulliaya S, Thippeswamy A, et al. 2012. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol. 44:73–77.
  • Toolabi T, Vanaki Z, Memarian R, et al. 2012. Quality of nursing documentations in CCU by hospital information system (HIS). J Crit Care Nurs. 5:53–62.
  • Zhang JH, Xu M. 2000. DNA fragmentation in apoptosis. Cell Res. 10:205–211.
  • Zhou S, Palmeira CM, Wallace KB. 2001. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett. 121:151–157.
  • Zordoky BNM, Anwar-Mohamed A, Aboutabl ME, et al. 2010. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol Appl Pharmacol. 242:38–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.